Pharmaceutical News

RSS

Viewpoints: Dems' abortion policies on the wrong side of public opinion; Doctors need to be more accurate in death reports

Last week saw two major developments in the legal and political battle over the Obama administration's sound decision to require most employers to provide free insurance coverage of contraceptives for women under the new health care law - one of them positive and the other a blow to the mandate and to religious liberty (7/1).

3 Jul 2013

Genentech's obinutuzumab gets FDA Priority Review for chronic lymphocytic leukemia

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has accepted the company's Biologics License Application for obinutuzumab (GA101) and granted Priority Review for GA101 in the treatment of chronic lymphocytic leukemia, one of the most common forms of blood cancer, based on final Stage 1 data from the pivotal CLL11 trial.

3 Jul 2013

Data on side effects of fidaxomicin not analysed appropriately

The antibiotic fidaxomicin (trade name: Dificlir) has been approved in Germany since December 2011 for the treatment of adults who have diarrhoea caused by Clostridium difficile.

3 Jul 2013

Key HIV drug prices continue to fall, but newer medicines still priced too high

International medical humanitarian organisation Médecins Sans Frontières today released its annual report Untangling the Web of ARV Price Reductions,at the International AIDS Society conference in Kuala Lumpur.

3 Jul 2013

Genetic variations can identify women who are likely to benefit from breast cancer prevention drug

Scientists found genetic variations that could be used to identify women who are most likely to benefit from a certain type of breast cancer prevention drug—and who should avoid it.

3 Jul 2013

Two-dimensional barcodes on vaccine improve safety of the U.S. immunization system, save millions

Using two-dimensional barcodes on vaccine product labels would enhance the safety of the U.S. immunization system and save more than $300 million by 2023, according to a study by researchers at RTI International and the U.S. Centers for Disease Control & Prevention.

3 Jul 2013

Abiraterone can prolong overall survival and delay severe pain in prostate cancer patients

Abiraterone acetate (abiraterone for short, trade name: Zytiga) has been approved in Germany since December 2012 for men with metastatic prostate cancer that is not responsive to hormone blockade, who only have mild symptoms or so far none at all, and in whom chemotherapy is not yet indicated.

3 Jul 2013

NIDA grants $3.3M to design vaccine conferring immunity to nicotine

A chemical component present in the nightshade family of plants is one of the world's most tenaciously addictive substances. It is the nicotine contained in tobacco and found in high concentrations in cigarettes. Smoking remains a global scourge; in the U.S. it is the leading source of preventable death.

3 Jul 2013

Salsalate lowers blood glucose and improves glycemic control in T2D, say scientists

Joslin scientists report that salsalate, a drug used to treat arthritis, lowers blood glucose and improves glycemic control in type 2 diabetes. These findings, which were published today by the Annals of Internal Medicine, provide additional evidence that salsalate may be an effective drug to treat type 2 diabetes.

3 Jul 2013

FDA-approved formoterol drug improves cognitive function in mouse model of Down syndrome

An existing FDA-approved drug improves cognitive function in a mouse model of Down syndrome, according to a new study by researchers at the Stanford University School of Medicine.

3 Jul 2013

ARIAD Pharmaceuticals' Iclusig gets EC marketing authorization for CML and Ph+ ALL treatment

ARIAD Pharmaceuticals, Inc. today announced that the European Commission has granted a marketing authorization for Iclusig (ponatinib) as an orphan medicinal product for two indications.

2 Jul 2013

Viewpoints: A 'clever' fix for contraception coverage; Sanjay Gupta warns doctors to pay attention to health overhaul

Many nonprofit religious organizations have balked at having to insure their employees' birth control -- because they don't believe in artificial contraception -- under the Affordable Care Act. On Friday, the Obama administration announced a solution to this problem. The new health care law guarantees access to preventive services, and contraception falls, appropriately, into that category (Carla Hill, 6/28).

2 Jul 2013

U.S. medical marijuana industry continues to grow as new bill legalizes MMJ in New Hampshire

As Neutra Corp. works to deliver new innovations to the U.S. medical marijuana industry, the market for those innovations continues to grow. Last week, lawmakers passed a bill to make New Hampshire the 19th state to approve medical marijuana prescriptions for patients with chronic or terminal illnesses.

2 Jul 2013

FDA sends Complete Response Letter to Merck regarding investigational drug for insomnia

Merck, known as MSD outside the United States and Canada, announced today that the company has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application for suvorexant, Merck's investigational medicine for the treatment of insomnia.

2 Jul 2013

Cannabis users appear to lack motivation

Researchers found that dopamine levels in a part of the brain called the striatum were lower in people who smoke more cannabis and those who began taking the drug at a younger age.

2 Jul 2013

UCSF researchers find that vitamin C may help stem cells, in vitro fertilization

Vitamin C affects whether genes are switched on or off inside mouse stem cells, and may thereby play a previously unknown and fundamental role in helping to guide normal development in mice, humans and other animals, a scientific team led by UC San Francisco researchers has discovered.

2 Jul 2013

Contraceptive exemption for religious groups finalized

The rule, issued under the health care law, attempts to quell the controversy by balancing the interests of women with the concerns of the Roman Catholic Church and other employers with religious objections to providing coverage for contraceptives.

2 Jul 2013

New UCLA-led study examines content of doctor-patient conversations about dietary supplements

Vitamins, minerals, herbs and other dietary supplements are widely available in supermarkets and drug stores across the nation without a prescription, so it's no surprise that nearly half of all Americans take them.

2 Jul 2013

Genentech's Perjeta regimen gets FDA Priority Review for HER2-positive early stage breast cancer

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has accepted the company's supplemental Biologics License Application for the use of a Perjeta (pertuzumab) regimen before surgery (neoadjuvant treatment) in people with HER2-positive early stage breast cancer.

2 Jul 2013

Depression calculator to predict likelihood of antidepressant response in individual patients

As in any other field of medicine, when a depressed person visits a psychiatrist for treatment of depression, they like to be informed of the odds that they will respond to the medication they are prescribed. Unfortunately, there has been no precise way to predict antidepressant response in individual patients.

2 Jul 2013

Pharmaceutical News

Viewpoints: Dems' abortion policies on the wrong side of public opinion; Doctors need to be more accurate in death reports

Genentech's obinutuzumab gets FDA Priority Review for chronic lymphocytic leukemia

Data on side effects of fidaxomicin not analysed appropriately

Key HIV drug prices continue to fall, but newer medicines still priced too high

Genetic variations can identify women who are likely to benefit from breast cancer prevention drug

Two-dimensional barcodes on vaccine improve safety of the U.S. immunization system, save millions

Abiraterone can prolong overall survival and delay severe pain in prostate cancer patients

NIDA grants $3.3M to design vaccine conferring immunity to nicotine

Salsalate lowers blood glucose and improves glycemic control in T2D, say scientists

FDA-approved formoterol drug improves cognitive function in mouse model of Down syndrome

ARIAD Pharmaceuticals' Iclusig gets EC marketing authorization for CML and Ph+ ALL treatment

Viewpoints: A 'clever' fix for contraception coverage; Sanjay Gupta warns doctors to pay attention to health overhaul

U.S. medical marijuana industry continues to grow as new bill legalizes MMJ in New Hampshire

FDA sends Complete Response Letter to Merck regarding investigational drug for insomnia

Cannabis users appear to lack motivation

UCSF researchers find that vitamin C may help stem cells, in vitro fertilization

Contraceptive exemption for religious groups finalized

New UCLA-led study examines content of doctor-patient conversations about dietary supplements

Genentech's Perjeta regimen gets FDA Priority Review for HER2-positive early stage breast cancer

Depression calculator to predict likelihood of antidepressant response in individual patients

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News